Recruiting NA Class II Malocclusion

New treatment option for Class II Malocclusion

Official title Ready-made vs. Custom-made Carriere Motion Appliance

ClinicalTrials.gov ID: NCT07361172

What this study is testing

What it's testing
The aim of this study is to evaluate the effect of custom-made CMA vs. the ready-made CMA.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 12 to 16

You may be able to join if

  • Patients age (12-15) years.
  • Full permanent dentition.
  • Class II malocclusion with at least an end-on Class II molar relationship bilaterally.

You likely can't join if

  • Systemic conditions that may interfere with the treatment.
  • Bad habits that might jeopardize the appliance.
  • Transverse discrepancy.
  • Previous orthodontic treatment.

The study team makes the final eligibility decision.

Where it's taking place

  • Al Mansurah, Adakhlia, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 12 years to 16 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Al Mansurah, Adakhlia, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.